Total neoadjuvant treatment and PD-1/PD-L1 checkpoint inhibitor in locally advanced rectal cancer

For local advanced rectal cancer (LARC), total neoadjuvant treatment (TNT) has shown more complete response (CR), reduced risk of distant metastasis (DM) and increase of the sphincter preservation rate. Now it is the one and only recommendation for high-risk group of LARC according to National Compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Weiwei, Luo, Huilong, Yao, Ye, Wang, Yaqin, Liu, Shuang, Sun, Rui, Chen, Gong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079866/
https://www.ncbi.nlm.nih.gov/pubmed/37033988
http://dx.doi.org/10.3389/fimmu.2023.1149122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079866/
https://www.ncbi.nlm.nih.gov/pubmed/37033988
http://dx.doi.org/10.3389/fimmu.2023.1149122

Ejemplares similares